← Back to patent-cliff list
布地奈德 (Shire)
Tier C — Watch / tradeBudesonide (Shire)
Verus Pharmaceuticals
Originator
2024
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：GR
Brand：Eohilia
Indications (approved)：嗜酸性粒细胞性食管炎
Regional status
US
批准上市
2024-02-09
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Budesonide (Shire)?
Approved indications include: 嗜酸性粒细胞性食管炎.
When does the Budesonide (Shire) patent expire?
No public expiry year is available for Budesonide (Shire) yet; this page updates once verified.
How do I get a quote for Budesonide (Shire) intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25